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Recently, 14 persons in southeastern Florida were iden-
tiﬁ  ed with Neisseria meningitidis serogroup W135 invasive 
infections. All isolates tested had matching or near-match-
ing pulsed-ﬁ  eld gel electrophoresis patterns and belonged 
to the multilocus sequence type 11 clonal complex. The epi-
demiologic investigation suggested recent endemic trans-
mission of this clonal complex in southeastern Florida.
N
eisseria meningitidis serogroup W135, which gener-
ally accounts for <5% of invasive meningococcal dis-
ease in the United States, has frequently been associated 
with foreign travel and is less often associated with out-
breaks than other serogroups (1). In Florida during 2004–
2007, a total of 337 patients statewide were reported to 
have meningococcal disease; 6 (1.8%) of these were caused 
by serogroup W135.
The Study
Meningococcal disease is a reportable condition in 
Florida. Isolates of N. meningitidis from persons with in-
vasive disease are forwarded to the state health department 
Bureau of Laboratories for serogrouping by slide agglutina-
tion. Isolates from outbreaks or clusters are further charac-
terized by pulsed-ﬁ  eld gel electrophoresis (PFGE) by using 
NheI and SpeI restriction enzymes and methods consistent 
with standard protocols (2).
From December 2008 through April 2009, we ob-
served an increase of invasive meningococcal disease 
caused by serogroup W135 in southeastern Florida totaling 
13 patients, of whom 9 had indistinguishable PFGE pat-
terns (Figure 1). Isolates from the 4 other case-patients had 
PFGE patterns differing by 1 (pattern II), 2 (pattern III), 
and 5 bands (pattern IV), making them >94% related to the 
dominant pattern. A retrospective review of all 5 W135 iso-
lates in Florida from January 2007 through November 2008 
identiﬁ  ed 1 additional isolate matching the dominant pattern 
from a resident of southeastern Florida with illness onset in 
May 2008. The 4 other isolates from 2007–2008 had PFGE 
patterns <80% related (Figure 1) and occurred before May 
2008 in residents of central and northern Florida.
Of the 14 case-patients with matching or near-match-
ing PFGE patterns (Table 1), 13 denied recent foreign 
travel. One patient with disease onset in April 2009 was a 
tourist visiting Miami from the United Kingdom. Eleven 
(79%) case-patients resided in or were visiting Miami-
Dade County, 2 (14%) resided in Broward County, and 1 
(7%) was a resident of Palm Beach County. Of the 14 case-
patients, the median age was 45 years (range 1–84). Eight 
(57%) case-patients were female, 7 (50%) were Hispanic; 
8 were white, and 6 were black. Twelve patients had a bac-
teremia syndrome, 2 had meningitis, and 1 had pneumonia 
in addition to bacteremia. Four of 14 patients died, all with 
bacteremia. The epidemiologic investigation has not identi-
ﬁ  ed any common exposures, social settings, or other con-
nections among patients in this series. Six (43%) case-pa-
tients had onset of illness within 10 days of their birthdays 
(binomial probability, p<0.0001), but no obvious detailed 
exposures were identiﬁ  ed related to this observation.
Illness onset for the 14 W135 patients in this clus-
ter is shown in relation to onset for all 38 meningococcal 
disease patients with other serogroups identiﬁ  ed in Flor-
ida during the same 12-month period (Figure 2). Demo-
graphic and clinical factors were also compared between 
these serogroup W135 and non-W135 patients (Table 2). 
As a group, serogroup W135 patients were older, were 
more likely to be Hispanic and to reside in or be visit-
ing the southeastern 3-county region, were more likely to 
have bacteremia, and had higher mortality rates than non-
W135 serogroup patients. However, other than Hispanic 
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Figure 1. Pulsed-ﬁ  eld gel electrophoresis (PFGE) patterns for 14 
related and 4 unrelated isolates of Neisseria meningitidis serogroup 
W135, Florida, USA.ethnicity and residence in the southeastern region, none of 
these differences were signiﬁ  cant.
Twelve isolates from the Florida cluster were forward-
ed to Centers for Disease Control and Prevention laborato-
ries for antimicrobial susceptibility testing. All 12 isolates 
were sensitive to all antimicrobial agents tested (penicil-
lin G, ceftriaxone, ciproﬂ  oxacin, rifampin, azithromycin). 
Seven of these isolates underwent additional molecular 
characterization with PCR and multilocus sequence typing 
by using methods previously described (1,3). The isolates 
were conﬁ  rmed as serogroup W135 by real-time PCR with 
primers speciﬁ  c for serogroups A, B, C, W135, X, and Y. 
These isolates were also found to belong to the sequence 
type (ST)-11/electrophoretic type 37 clonal complex.
The dominant PFGE pattern seen in the Florida clus-
ter is designated H46N06.0068, and is closely related to 
the pattern observed in the large multicountry outbreak 
associated with Hajj pilgrims occurring in 2000 (1). The 
2000 outbreak involved >400 cases and was caused by a 
single clone of the ST-11 clonal complex. In recent years, 
increases in serogroup W135 have been noted in northern 
Argentina (4) and southern Brazil (5). Among serogroup 
W135 isolates in these countries, the most common clone 
has been the hypervirulent ST-11 complex (4,5).
From 1997 through 2006, the annual incidence 
of meningococcal disease in Florida declined gradu-
ally from ≈1.2 to 0.4 cases per 100,000 population (6). 
Historical trends of surveillance data in Florida suggest 
seasonal peaks of meningococcal disease during Novem-
ber–May, corresponding to the winter dry season, when 
tourist visitors and part-time residents are most likely 
to visit. The 3-county region of southeastern Florida in 
which this W135 cluster occurred had an estimated pop-
ulation in 2008 of >5.5 million inhabitants; 2.4 million 
of these reside in Miami-Dade County, where >60% of 
residents are Hispanic. During December 2008 through 
April 2009, the 32 total patients with meningococcal dis-
ease reported in the state represent an annual incidence of 
0.41 cases/100,000 Florida residents. The 19 total cases 
(13 serogroup W135) in the 3-county region during this 
period represent an annual population incidence of 0.82 
cases/100,000 residents in these counties. For the 13 total 
cases occurring in Miami-Dade County during this period 
(11 serogroup W135), the annual incidence would be 1.26 
cases/100,000 residents in the county. During May 2009, 
no cases of serogroup W135 meningococcal disease were 
reported anywhere in the state. In the absence of a more 
narrowly deﬁ   ned risk group, the cluster of serogroup 
W135 case-patients described in this report is still far be-
low the threshold for recommending vaccination control 
efforts (10 cases/100,000 over 3 months) (7).
DISPATCHES
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Table 1. Demographic and clinical characteristics of patients with serogroup W135 meningococcal disease, southeastern Florida, 
USA, 2008–2009* 
Case
ID
Age, y/ 
sex  Race
Hispanic
ethnicity  County 
Month of 
onset
Onset near 
birthday†  Syndrome 
Specimen
source Outcome
PFGE 
group
1 39/M White Y Broward  2008  May  Y  B Blood Survived 1
2 1/M White Y Miami-Dade 2008  Dec  Y  M CSF Survived 1
3 29/M White Y  Palm Beach  2009 Jan  N M CSF Survived 1
4 83/M White Y  Miami-Dade 2009 Jan  Y  B, P  Blood Died 1
5 84/F White Y Miami-Dade 2009  Jan  N B Blood Survived 1
6 26/F Black N Miami-Dade 2009 Jan  Y  B Blood Survived 1
7 70/M White Y Miami-Dade 2009  Feb  N B Blood Survived 1
8 50/F Black N Miami-Dade 2009 Feb  N B Blood Survived 1
9 77/F Black N Miami-Dade 2009 Feb  N B Blood Survived 2
10 58/F Black N Broward 2009  Mar  Y  B Blood Died 4
11 20/F White N Miami-Dade 2009 Mar  N B Blood Died 1
12 69/F White Y Miami-Dade 2009  Apr  N B Blood Survived 4
13 26/F Black N Miami-Dade‡ 2009 Apr  Y  B Blood Died 3
14 19/M Black N Miami-Dade 2009 Apr  N B Blood Survived 1
*ID, identification; PFGE, pulsed-field gel electrophoresis; B, bacteremia; M, meningitis; CSF, cerebrospinal fluid; P, pneumonia.  
†Within 10 days, before or after. 
‡Foreign tourist visitor to Miami-Dade County. 
Figure 2. Conﬁ  rmed meningococcal disease cases, by month of 
onset, Florida, USA, May 2008–April 2009.Serogroup W135 Meningococci, Southeastern Florida
Conclusions
Southeastern Florida is considered the gateway to the 
Americas, with extensive social, cultural, and commercial 
ties to Central and South America and the Caribbean. The 
dominant clonal complex observed in the Florida cluster 
matches the dominant type recently observed in Argentina 
and Brazil, raising the possibility of introduction to south-
eastern Florida from South America. Taken together, these 
observations suggest the possible establishment of a clonal 
complex of serogroup W135 meningococci in southeastern 
Florida with subsequent endemic transmission.
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Table 2. Characteristics of patients with serogroup W135 and 
non-W135 meningococcal disease, Florida, USA, May 2008–
April 2009 
No. positive/no. tested (%)
Variable
W135,
n = 14 
Non-W135,
n = 38  p value*
Female sex  8/14 (57)  22/38 (58)  1.00
White race  8/14 (57)  30/38 (79)  0.16
Hispanic ethnicity  7/14 (50)  7/38 (18)  0.04
Residence in southeast 
region
14/14 (100)  12/38 (32)  <0.0001
Bacteremia 12/14 (86)  24/38 (63)  0.18
Meningitis 2/14 (14)  13/38 (34)  0.30
Pneumonia 1/14 (7)  5/38 (13)  1.00
Death 4/14 (29)  4/38 (11)  0.19
*By 2-sided Fisher exact test used for categorical variables; Wilcoxon 
rank-sum test used for age. Median age for W135 patients, 45 years; 
median age for non-W135 patients, 27 years; p value = 0.07. 